Dark Horse Sponsors Phacilitate Leaders World 2019 meeting in Miami

January 21, 2019
Categories
Miami Buildings and Beach

Campbell, CA, January 21st, 2019 – Dark Horse Consulting, the leading consultancy specializing in cell and gene therapy product development, today announced its planned attendance and sponsorship of the 2019 Phacilitate Leaders World meeting, scheduled for January 22-25 in Miami, FL.

“The Phacilitate meetings are amongst the world’s most influential events for the cell & gene therapy community, and we are proud to contribute to the Leaders World meeting in Miami as a silver sponsor,” said Anthony Davies, PhD, Founder and CEO of Dark Horse Consulting. “We are looking forward to hearing updates from speakers and round-table discussions, catching up with many of our clients in our bespoke lobby lounge, and making new connections throughout the week”

The Phacilitate Leaders World meeting is a four-day conference featuring presentations by leading companies in the space, many new features this year such as an Asia Pavilion, a Clinical Hub, sessions on Ethics and Policy, and the world’s largest advanced therapies partnering event.  These meetings bring together top decision-makers in the industry with researchers and clinical experts from around the globe, fostering key partnerships and advancing the industry to ultimately bring more cures to patients.

Dr Davies will be chairing the Pre-Conference Super Plenary, titled “The Next 15 Years for Advanced Therapies” at 6PM on Tuesday evening, conducting fireside chats with thought leaders in the field, before introducing the keynote speaker, Dr Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) at the FDA.  Dr Davies will also chair a session on Wednesday, January 23rd, titled “The Beauty and Curse of Being First” and will participate in a workshop promoted by Miltenyi Biotec on Thursday, January 24th, titled “Towards commercialization – accomplish the challenges of autologous Cell and Gene Therapies”.

Top executives and consultants from Dark Horse Consulting will be in attendance throughout the entirety of the conference.  They are available for scheduled 1-on-1 meetings, or impromptu meetings at the Dark Horse Lobby area or partnering suite during the Partnering Forum.  To schedule a meeting with Dark Horse Consulting at the Phacilitate Leaders World Partnering Forum, email us directly at contactus@darkhorseconsulting.us.

About Dark Horse Consulting

Dark Horse Consulting specializes in the development of cell and gene therapy products. All of our consultants have deep cell and gene therapy industry experience, spanning diverse functions including process development, device development, manufacturing, quality, regulatory, program management, business development, strategy, and financing/investor relations. Many of our consultants also bring experience from adjacent more mature sectors, including traditional biologics, small molecules, medical devices, and management consulting. As a result, we deeply understand the unique challenges faced by cell and gene Therapy developers and are able to apply best practices from other industries to address the needs of our clients.

About Phacilitate Leaders World

Phaciliate Leaders World is the world’s largest interdisciplinary event dedicated to Advanced Therapies and Regenerative Medicine, the one meeting on the global calendar attended by all of the critical decision-makers from every stakeholder in the field. The ambitious and comprehensive agenda will inform attendees about all aspects driving the commercialization of advanced therapies on topics including immuno-oncology, cord blood, regulatory pathways, reimbursement, research and development, emerging science, translation and clinical trials, regenerative medicine in the clinic, ethics and regulation, patient advocacy, funding and much more.

Related Posts

Join the Quarter Horse Newsletter

We’ll send you a quarterly newsletter all things DHC!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.